[go: up one dir, main page]

DK3016666T3 - Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom - Google Patents

Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom Download PDF

Info

Publication number
DK3016666T3
DK3016666T3 DK14811285.7T DK14811285T DK3016666T3 DK 3016666 T3 DK3016666 T3 DK 3016666T3 DK 14811285 T DK14811285 T DK 14811285T DK 3016666 T3 DK3016666 T3 DK 3016666T3
Authority
DK
Denmark
Prior art keywords
reservatrol
delaying
disease
derivatives
treating
Prior art date
Application number
DK14811285.7T
Other languages
English (en)
Inventor
Janne Sande Mathisen
Henrik Mathisen
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52022528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3016666(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smartfish As filed Critical Smartfish As
Application granted granted Critical
Publication of DK3016666T3 publication Critical patent/DK3016666T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK14811285.7T 2013-06-13 2014-06-13 Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom DK3016666T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361834455P 2013-06-13 2013-06-13
PCT/NO2014/050099 WO2014200356A1 (en) 2013-06-13 2014-06-13 A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease

Publications (1)

Publication Number Publication Date
DK3016666T3 true DK3016666T3 (da) 2019-07-01

Family

ID=52022528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14811285.7T DK3016666T3 (da) 2013-06-13 2014-06-13 Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom

Country Status (14)

Country Link
US (1) US9717704B2 (da)
EP (1) EP3016666B1 (da)
JP (2) JP6648007B2 (da)
KR (1) KR20160018801A (da)
CN (1) CN105283190A (da)
AU (1) AU2014278839B2 (da)
CA (1) CA2914767A1 (da)
DK (1) DK3016666T3 (da)
ES (1) ES2732307T3 (da)
MX (1) MX363853B (da)
PL (1) PL3016666T3 (da)
PT (1) PT3016666T (da)
SI (1) SI3016666T1 (da)
WO (1) WO2014200356A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516814A (ja) 2013-04-19 2016-06-09 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー コンブレタスタチン類似体
SI3016666T1 (sl) * 2013-06-13 2019-09-30 Smartfish As Formulacija olja iz morskih vrst, ki vsebuje resveratrol ali njegove derivate za uporabo v zdravljenju, odlaganju in/ali preprečevanju Alzheimerjeve bolezni
US9840692B2 (en) 2013-06-24 2017-12-12 Wilson Wolf Manufacturing Closed system device and methods for gas permeable cell culture process
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
CA2940694A1 (en) 2014-03-31 2015-10-08 Board Of Trustees Of The University Of Arkansas Disubstituted triazole analogs
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
US20200024249A1 (en) * 2017-02-02 2020-01-23 Bioventures, Llc Methods of protecting against neurodegeneration

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US6184248B1 (en) * 1996-09-05 2001-02-06 Robert K. K. Lee Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
NO313076B1 (no) * 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
US6964969B2 (en) * 2001-04-19 2005-11-15 Mccleary Edward Larry Composition and method for treating impaired or deteriorating neurological function
ES2687657T3 (es) 2003-05-27 2018-10-26 Dsm Ip Assets B.V. Nuevas composiciones nutracéuticas y uso de las mismas
NO322041B1 (no) 2004-10-22 2006-08-07 Pharmalogica As Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling.
US20060172012A1 (en) * 2005-01-28 2006-08-03 Finley John W Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks
NO323665B1 (no) 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
US20090202679A1 (en) 2005-11-29 2009-08-13 Pharmalogica As Composition comprising fish oil and juices
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
DE202007013532U1 (de) * 2007-09-26 2007-12-13 Orthomol Pharmazeutische Vertriebs Gmbh Zusammensetzung enthaltende Phospholipide, geeignet zur Stärkung der Gehirn- und Gedächtnisfunktion
NO20081487L (no) 2008-03-27 2009-09-28 Smartfish As Helsefremmende drikk
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
EP2279667A1 (en) * 2009-07-30 2011-02-02 Brudy Technology, S.L. Vegetable and marine oil or fat compositions enriched with DHA or EPA and C18 or higher fatty acid
WO2012025229A1 (en) * 2010-08-27 2012-03-01 Persavita Ltd. Composition and method of manufacture
US10010566B2 (en) * 2011-03-18 2018-07-03 NestecSA Compositions and methods useful for ameliorating age related maladies
WO2014000264A1 (en) 2012-06-29 2014-01-03 Qualcomm Incorporated Td-scdma rscp measurement correlation
SI3016666T1 (sl) * 2013-06-13 2019-09-30 Smartfish As Formulacija olja iz morskih vrst, ki vsebuje resveratrol ali njegove derivate za uporabo v zdravljenju, odlaganju in/ali preprečevanju Alzheimerjeve bolezni

Also Published As

Publication number Publication date
KR20160018801A (ko) 2016-02-17
SI3016666T1 (sl) 2019-09-30
CA2914767A1 (en) 2014-12-18
EP3016666B1 (en) 2019-05-15
PL3016666T3 (pl) 2019-09-30
HK1223263A1 (en) 2017-07-28
ES2732307T3 (es) 2019-11-21
MX363853B (es) 2019-04-05
EP3016666A4 (en) 2017-03-15
JP6648007B2 (ja) 2020-02-14
MX2015016931A (es) 2016-04-04
US9717704B2 (en) 2017-08-01
PT3016666T (pt) 2019-07-11
JP2016523857A (ja) 2016-08-12
US20150031653A1 (en) 2015-01-29
AU2014278839A1 (en) 2015-12-10
EP3016666A1 (en) 2016-05-11
JP2019081807A (ja) 2019-05-30
AU2014278839B2 (en) 2019-06-20
CN105283190A (zh) 2016-01-27
WO2014200356A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
HUS2400023I1 (hu) Készítmények és módszerek anémia kezelésére
DK3016666T3 (da) Fiskeolieformulering omfattende reservatrol eller derivater deraf til anvendelse ved behandling, forsinkelse og/eller forebyggelse af Alzheimers sygdom
BR112016026378A2 (pt) formulações e métodos para tratamento com queratina
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
DK3444261T3 (da) 2,2-difluorpropionamidderivat af bardoxolonmethyl, farmaceutiske sammensætninger og polymorfer deraf til anvendelse ved behandling af visse lidelser
SI3129355T1 (sl) Fungicidni derivati N'-(2-metil-6-(2-alkoksi-etoksi)-3-piridil)-N-alkil-formamida za uporabo v poljedelstvu
BR112015031475A2 (pt) composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
DK3004110T3 (da) Pyrazolpyrrolidin-derivater og disses anvendelse ved behandlingen af sygdom
HUE054783T2 (hu) Pridopidin Huntington-kór kezelésében
DK4374873T3 (da) Middel til brug ved behandling eller forebyggelse af oftalmologiske tilstande
FR3003568B1 (fr) Composition comprenant hf et 3,3,3-trifluoro-2-chloropropene
HUE036224T2 (hu) C1-gátló készítmények örökletes angioödéma megelõzésében és kezelésében történõ alkalmazásra
CL2014002348A1 (es) Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
DK3458020T3 (da) Forbindelser til at fremme hårvækst og/eller at hæmme eller forsinke hårtab hos mennesker, og sammensætninger til sådanne anvendelser
HUE046671T2 (hu) Glutárimid származékokat tartalmazó gyógyászati készítmény, valamint ennek alkalmazása eozinofil betegségek kezelésében
DK3302519T3 (da) Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom
DK3019129T3 (da) Øjenmaske til bedring eller forebyggelse af tørre øjne og lignende
DK2991507T3 (da) Anvendelse af en sammensætning omfattende fiskeolie og juice til behandling og/eller efterbehandling af cancer
DK4005570T3 (da) Pridopidin til anvendelse behandling af retts syndroe
DK3086784T3 (da) Bicalutamid analoger eller (s)-bicalutamid som exocytose aktiverende forbindelser til brug i behandling af lysosomal lagringssygdom eller glycogenose
SI3268374T1 (sl) KV1.3 inhibitorji in njihova medicinska uporaba
PL3732294T3 (pl) Tymohydrochinon do stosowania w leczeniu hiperglikemii
DK3383872T3 (da) 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
IL253368B (en) Oil blends, processes for the preparation thereof and their use in formulas